T 1581/12 (Outer membrane protein immunogen Neisseria/GLAXOSMITHKLINE) of 15.9.2016

European Case Law Identifier: ECLI:EP:BA:2016:T158112.20160915
Date of decision: 15 September 2016
Case number: T 1581/12
Application number: 05077865.3
IPC class: C12N 15/31
C07K 14/22
C07K 16/12
C12Q 1/68
A61K 39/095
G01N 33/50
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 558 KB)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Neisseria antigens and compositions
Applicant name: GlaxoSmithKline Biologicals S.A.
Opponent name: Wyeth et al.
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention Art 114(2)
European Patent Convention Art 123(2)
European Patent Convention Art 76(1)
European Patent Convention Art 52
European Patent Convention Art 57
European Patent Convention Art 83
European Patent Convention Art 54
European Patent Convention Art 56
Rules of procedure of the Boards of Appeal Art 13(1)
Rules of procedure of the Boards of Appeal Art 13(3)
Rules of procedure of the Boards of Appeal Art 12(4)
Keywords: Main Request - admissibility (yes);
Main Request - meets all requirements of the EPC (yes)
Catchwords:

-

Cited decisions:
G 0010/91
T 0301/87
T 1329/04
T 0898/05
T 0018/09
T 0583/09
T 1451/09
T 2134/10
Citing decisions:
T 1259/16

Source: http://www.epo.org/law-practice/case-law-appeals/recent/t121581eu1.html

Date retrieved: 17 May 2021

18 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Case Law Book: II Conditions to be met by an Application

Case Law of the Enlarged Board

General Case Law